CtDNA: An emerging neoadjuvant biomarker in resectable solid tumors.

ABSTRACT: Christopher Abbosh and Charles Swanton discuss circulating tumor DNA as a potential biomarker for neoadjuvant treatment response in solid tumors.

SUBMITTER: Abbosh C 

PROVIDER: S-EPMC8509880 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature